Cogent Biosciences Inc (NASDAQ: COGT) flaunted slowness of -4.31% at $35.52, as the Stock market unbolted on Wednesday, before settling in for the price of $37.12 at the close. Taking a more long-term approach, COGT posted a 52-week range of $3.72-$43.73.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 10.02%. Meanwhile, its Annual Earning per share during the time was 10.02%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.10%. This publicly-traded company’s shares outstanding now amounts to $139.83 million, simultaneously with a float of $123.61 million. The organization now has a market capitalization sitting at $5.40 billion. At the time of writing, stock’s 50-day Moving Average stood at $31.56, while the 200-day Moving Average is $14.85.
Cogent Biosciences Inc (COGT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Cogent Biosciences Inc industry. Cogent Biosciences Inc’s current insider ownership accounts for 18.71%, in contrast to 87.49% institutional ownership. According to the most recent insider trade that took place on Dec 26 ’25, this organization’s Chief Legal Officer sold 65,000 shares at the rate of 38.70, making the entire transaction reach 2,515,500 in total value, affecting insider ownership by 109,398. Preceding that transaction, on Dec 26 ’25, Company’s Chief Financial Officer sold 77,000 for 38.68, making the whole transaction’s value amount to 2,978,360. This particular insider is now the holder of 131,834 in total.
Cogent Biosciences Inc (COGT) Earnings and Revenue Records
Cogent Biosciences Inc’s EPS increase for this current 12-month fiscal period is 8.10% and is forecasted to reach -1.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 44.75% through the next 5 years, which can be compared against the 10.02% growth it accomplished over the previous five years trading on the market.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Let’s observe the current performance indicators for Cogent Biosciences Inc (COGT). It’s Quick Ratio in the last reported quarter now stands at 6.38.
In the same vein, COGT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.37, a figure that is expected to reach -0.52 in the next quarter, and analysts are predicting that it will be -1.78 at the market close of one year from today.
Technical Analysis of Cogent Biosciences Inc (COGT)
Now, what If we examine the latest scores posted by [Cogent Biosciences Inc, COGT]. During the last 5-days, its volume was lower the volume of 2.27 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 17.74% While, its Average True Range was 33.27.
Raw Stochastic average of Cogent Biosciences Inc (COGT) in the period of the previous 100 days is set at 75.13%, which indicates a major rise in contrast to 16.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.83 that was higher than 1.27 volatility it exhibited in the past 100-days period.
